These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 16120060)

  • 1. Changes in the usage of antihypertensive drugs: implications and prospects.
    Schachter M
    Br J Clin Pharmacol; 2005 Sep; 60(3):231-4. PubMed ID: 16120060
    [No Abstract]   [Full Text] [Related]  

  • 2. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
    Altagracia-Martínez M; Kravzov-Jinich J; Guadarrama-Atrizco MD; Rubio-Poo C; Wertheimer AI
    Res Social Adm Pharm; 2006 Mar; 2(1):22-37. PubMed ID: 17138499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoepidemiology of antihypertensive drugs in primary care setting of Bahrain between 1998 and 2000.
    Al Khaja KA; Sequeira RP
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):741-8. PubMed ID: 16342299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choice of antihypertensive drugs in the European Society of Hypertension-European Society of Cardiology guidelines: specific indications rather than ranking for general usage.
    Mancia G; Zanchetti A;
    J Hypertens; 2008 Feb; 26(2):164-8. PubMed ID: 18192825
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihypertensive pharmacotherapy in a developing economy: pattern, acquisition costs and conformity to international guidelines in a tertiary-care setting.
    Amira CO; Okubadejo NU
    J Hum Hypertens; 2006 Nov; 20(11):894-7. PubMed ID: 16915299
    [No Abstract]   [Full Text] [Related]  

  • 6. Calcium antagonist and beta blocker regimens found equally effective in hypertensive patients with coronary artery disease.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Jan; 15(2):1, 5-6. PubMed ID: 14994735
    [No Abstract]   [Full Text] [Related]  

  • 7. Influencing prescribing patterns.
    Huston P; Campbell NR
    Can Fam Physician; 1998 Feb; 44():221-3, 228-30. PubMed ID: 9512821
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of ASCOT on hypertension treatment and guidelines in older adults.
    Sheridan R; Baldwin N
    Age Ageing; 2006 May; 35(3):214-7. PubMed ID: 16638764
    [No Abstract]   [Full Text] [Related]  

  • 9. Patterns of antihypertensive prescribing, discontinuation and switching among a Hong Kong Chinese population from over one million prescriptions.
    Wong MC; Jiang JY; Lam AT; Fung H; Griffiths S; Mercer SW
    J Hum Hypertens; 2008 Oct; 22(10):714-6. PubMed ID: 18650836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current problems in hypotensive treatment].
    Sznajderman M
    Wiad Lek; 1983 Mar; 36(5):413-24. PubMed ID: 6135281
    [No Abstract]   [Full Text] [Related]  

  • 11. [Revised guidelines for antihypertensive treatment. What is relevant for the general practitioner?].
    Zidek W
    MMW Fortschr Med; 2004 Jan; 146(1-2):37-8. PubMed ID: 18437867
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effects of antihypertensive drugs on lipid metabolism. Part I. Diuretics, beta-blockers, calcium antagonists].
    Martynov AI; Ostroumova OD; Mamaev VI; Rybkina TE; Kuznetsov VI; Tikhonova LIa; Smirnova MV
    Klin Med (Mosk); 2001; 79(8):8-12. PubMed ID: 11588795
    [No Abstract]   [Full Text] [Related]  

  • 13. Current role of beta-blockers in the treatment of hypertension.
    Aronow WS
    Expert Opin Pharmacother; 2010 Nov; 11(16):2599-607. PubMed ID: 20426702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of beta-adrenergic receptor blocking agents in hypertensive diseases: personal thoughts as the controversy persists.
    Frohlich ED
    Ther Adv Cardiovasc Dis; 2009 Dec; 3(6):455-64. PubMed ID: 19897523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in prescribing calcium-channel blockers.
    Opie LH
    Lancet; 1998 Nov; 352(9141):1708. PubMed ID: 9853466
    [No Abstract]   [Full Text] [Related]  

  • 16. Patterns in the drug treatment of hypertension in Auckland, 1982-7.
    Sinclair B; Jackson R; Beaglehole R
    N Z Med J; 1989 Sep; 102(876):491-3. PubMed ID: 2797571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ca antagonist in the guidelines for the management of hypertension (JSH 2004)].
    Umemura S
    Clin Calcium; 2005 Oct; 15(10):1599-608. PubMed ID: 16199904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations?
    Hilgers KF; Mann JF
    Nephrol Dial Transplant; 2008 Nov; 23(11):3389-91. PubMed ID: 18687734
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypertension in an urban population--who is treated with what and how well?
    Li C; Hedblad B; Berglund G; Janzon L
    J Hum Hypertens; 2007 Apr; 21(4):323-6. PubMed ID: 17273156
    [No Abstract]   [Full Text] [Related]  

  • 20. Characteristics of antihypertensive medication and change of prescription over 1 year of follow up in Japan: Fukushima Research of Hypertension (FRESH).
    Yokokawa H; Sanada H; Goto A; Watanabe T; Felder RA; Jose PA; Eisner GM; Yasumura S
    Am J Hypertens; 2010 Dec; 23(12):1299-305. PubMed ID: 20725053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.